|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||85.56 / 116.49|
-- Provides outlook for 2019-2022, extending the company's targeted 3-5% revenue compound annual growth rate (CAGR) and updating its adjusted earnings goal to a 4-6% CAGR
New lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacity
Transaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern states
New Findings Demonstrate the Benefit of Using Genetic Markers to Aid Detection of Atrial Fibrillation
- Quest to participate as in-network provider of laboratory services for Horizon Blue Cross Blue Shield of New Jersey plan participants
QuestDirect Builds on Quest's existing consumer offerings available through the new and improved MyQuest patient platform that lets people access their lab results, schedule appointments and pay bills
Oxford Immunotec's T-SPOT®.TB Tuberculosis and Accutix™ Tick-Borne Disease Testing Services are Part of Quest Diagnostics' Portfolio of Innovative Infectious Disease Diagnostics Tests, Broadening Access in the United States
Arizona's leading diagnostic provider offers first artificial intelligence-based precision medicine platform for Alzheimer's disease
Quest to Acquire the Outreach Laboratory Service Operations of Marin General Hospital
-- Third quarter revenues of $1.89 billion, up 1.8% from 2017
Relationship to expand access to quality, high value and innovative services for people in Flint and surrounding communities
Four Presentations Reveal Genetic Insights from Quest's Advanced Diagnostics
Bolsters company's expert screening and intervention services for employers and managed populations
The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation
PhenoPath deepens Quest's presence in the Pacific Northwest while extending the company's capabilities in anatomic pathology and molecular oncology
Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United States
Bolsters Quest's leadership in advanced diagnostics for women's and reproductive health
- More than half of Americans tested misused their prescription drugs in 2017
- Number of positive tests for Lyme disease increased significantly between 2016 and 2017.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.